Generic-Drug Makers Urge Changes To User-Fee Law
The generic-drug lobby on Monday outlined its hopes for improving and renegotiating the 2012 user-fee law that exchanged industry cash for better approvals and inspections at the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article